AlphaStocks

AZN vs SCSC

ASTRAZENECA PLC vs SCANSOURCE, INC. — Side-by-Side Stock Comparison

AZN

ASTRAZENECA PLC

8.4

Strong Buy

$200.99

SCSC

SCANSOURCE, INC.

4.9

Weak

$36.54

AZN vs SCSC: Which is the Better Investment?

ASTRAZENECA PLC (AZN) scores 8.4/10 while SCANSOURCE, INC. (SCSC) scores 4.9/10 on AlphaStocks' composite model. ASTRAZENECA PLC has the higher composite rating of Strong Buy. On a P/E basis, SCANSOURCE, INC. trades at 12.2x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricAZNSCSC
Scores & Fundamentals
Composite Score8.4/104.9/10
RatingStrong BuyWeak
Price$200.99$36.54
P/E Ratio30.412.2
ROE21.9%7.4%
Market Cap$312B$807.9M
Fair Value$192.63
Dividend Yield1.6%
Sector Rank#3 of 1127#606 of 1127
Model Verdicts
PiotroskiStrongNeutral
BuffettStrongStrong
GrahamCautionAttractive
LynchNeutralCaution
GreenblattNeutralNeutral
View full AZNanalysis →View full SCSCanalysis →
Compare any two stocks →

AZN vs SCSC: Which Stock Scores Higher?

ASTRAZENECA PLC (AZN) and SCANSOURCE, INC. (SCSC) are among the most compared stocks in the S&P 500. AZN currently leads with a composite score of 8.4/10 (Strong Buy) compared to SCSC's 4.9/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer